AcousticaBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $380K

  • Investors
  • 12

AcousticaBio General Information

Description

Developer of advanced fluid processing technology designed to enable subcutaneous self-administration of therapeutics. The company's proprietary microgel technology enables the conversion of intravenously (IV) delivered biologic products into ultra-highly concentrated, small-volume subcutaneous injections, enabling patients to administer their life-saving therapies with reduced pain and discomfort and without long, costly hospital visits.

Contact Information

Website
www.acoustica.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 277 Broadway
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Advanced Manufacturing, HealthTech, Life Sciences
Corporate Office
  • 277 Broadway
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AcousticaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 14-Jul-2023 $380K Completed Generating Revenue
6. Early Stage VC 01-Feb-2022 Completed Startup
5. Accelerator/Incubator 29-Oct-2021 Completed Startup
4. Accelerator/Incubator 22-Apr-2021 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 11-Jan-2021 Completed Startup
To view AcousticaBio’s complete valuation and funding history, request access »

AcousticaBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of advanced fluid processing technology designed to enable subcutaneous self-administration of therapeutics. T
Drug Delivery
Cambridge, MA
5 As of 2025

Boston, MA
 

Morrisville, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AcousticaBio Competitors (6)

One of AcousticaBio’s 6 competitors is Elektrofi, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elektrofi Formerly VC-backed Boston, MA
Lindy Biosciences Venture Capital-Backed Morrisville, NC
Halozyme Therapeutics Formerly VC-backed San Diego, CA
Halozyme Surf Bio Formerly VC-backed Palo Alto, CA
Enable Injections Venture Capital-Backed Cincinnati, OH
To view AcousticaBio’s complete competitors history, request access »

AcousticaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AcousticaBio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
3CC | Third Culture Capital Venture Capital Minority
Exor PE/Buyout Minority
Reinforced Ventures Venture Capital Minority
Safar Partners Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

AcousticaBio FAQs

  • When was AcousticaBio founded?

    AcousticaBio was founded in 2021.

  • Where is AcousticaBio headquartered?

    AcousticaBio is headquartered in Cambridge, MA.

  • What is the size of AcousticaBio?

    AcousticaBio has 5 total employees.

  • What industry is AcousticaBio in?

    AcousticaBio’s primary industry is Drug Delivery.

  • Is AcousticaBio a private or public company?

    AcousticaBio is a Private company.

  • What is AcousticaBio’s current revenue?

    The current revenue for AcousticaBio is .

  • How much funding has AcousticaBio raised over time?

    AcousticaBio has raised $1.65M.

  • Who are AcousticaBio’s investors?

    National Institutes of Health, 3CC | Third Culture Capital, Exor, Reinforced Ventures, and Safar Partners are 5 of 12 investors who have invested in AcousticaBio.

  • Who are AcousticaBio’s competitors?

    Elektrofi, Lindy Biosciences, Halozyme Therapeutics, Halozyme Surf Bio, and Enable Injections are some of the 6 competitors of AcousticaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process